EpiCombi.AI

EpiCombi.AI is a spinout from Oxford University that focuses on genomics signature-driven therapeutics. Their main goal is to overcome epigenetic barriers in cancer complexity through the development of AI-derived, network-acting multi-targeted drugs. EpiCombi.AI utilizes advanced technology and genomic data to create innovative solutions for cancer treatment. Their achievements include the develo...